Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery  William C Oliver, MD, David N Fass, PhD, Gregory A Nuttall,

Slides:



Advertisements
Similar presentations
Manuel J. Antunes, MD, PhD, DSc 
Advertisements

Stephen R. Broderick, MD, MPHS 
Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.
David W. Barbara, MD, William J. Mauermann, MD, James R
“Lead from the front”: Participative leadership
In surgical training, practice makes…almost perfect
Cold-induced fluid extravasation during cardiopulmonary bypass in piglets can be counteracted by use of iso-oncotic prime  Marit Farstad, MD, Venny Lise.
Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery  Kazuto Yokoyama,
P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J
Same-day cancellation of cardiac surgery: A retrospective review at a large academic tertiary referral center  Mark M. Smith, MD, William J. Mauermann,
Personalized cardiac surgery: Can noninvasive flow imaging lead to individualized resection strategies for bicuspid aortopathy?  Nicholas D. Andersen,
Intrinsic cardiac stem cells are essential for regeneration
Sequela-free long-term survival of a 65-year-old woman after 8 hours and 40 minutes of cardiac arrest from deep accidental hypothermia  Marie Meyer, MD,
The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin.
Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass  E Takizawa, H Hiraoka, D Takizawa,
William M. DeCampli, MD, PhD 
Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only  Thierry P Carrel, MD, Mike Schwanda, MD,
Multilevel data analysis: What? Why? How?
How should we treat air leaks?
Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all  David Faraoni, MD,
Go on-pump or off-pump in diabetic patients?
Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model  Yusuke Iwata, MD, Toru Okamura, MD, Nobuyuki Ishibashi, MD,
The lord of the rings  Antonio Miceli, MD, PhD 
Hypogammaglobulinemia after cardiopulmonary bypass in infants
Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.
Igor E. Konstantinov, MD, PhD, FRACS 
Jennifer H. Huang, MD, Rachel Sunstrom, PA, Myrna Y
The variability of the mitral valve anatomy and terminology
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity  Cedric Manlhiot, PhD, Colleen.
It's not “just a shunt” but sometimes it should be…
Michele Gallo, MD, Gino Gerosa, MD 
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J
Stephen R. Broderick, MD, MPHS 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing.
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
The diabetes epidemic and its effect on cardiac surgery practice
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
David L. Joyce, MD  The Journal of Thoracic and Cardiovascular Surgery 
Guidelines should bother us, not comfort us
Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery  Christian.
Instrumental variable methods in clinical research
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
A fate worse than death  Jennifer S. Lawton, MD 
Attachment disorder in thoracoabdominal surgery
Individualized heparin and protamine management in infants and children undergoing cardiac operations  Massimiliano Codispoti, MD, Christopher A Ludlam,
Mycobacterium chimaera: The ethical duty to disclose the minimal risk of infection to exposed patients  Anita Nguyen, MBBS, C. Christopher Hook, MD, Joseph.
Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary.
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes  Sitaram M. Emani, MD  The Journal of Thoracic.
Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass  Sudip Ghosh, MD, Manuel Galiñanes,
Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis  Dorthe Viemose.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Increasing duration of deep hypothermic circulatory arrest is associated with an increased incidence of postoperative electroencephalographic seizures 
Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD 
Elevated flow rate during cardiopulmonary bypass is associated with fluid accumulation  Oddbjørn Haugen, MD, Marit Farstad, MD, PhD, Venny Kvalheim, MD,
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
First in line for robotic surgery: Would you want to know?
Commentary: Just say NO
Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations  William C Oliver, MD, Paula J Santrach, MD, Gordon.
Sunjay Kaushal, MD, PhD, Brody Wehman, MD 
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Charles W. Shepard, MD, Lazaros K. Kochilas, MD, Ronald M
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Presentation transcript:

Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery  William C Oliver, MD, David N Fass, PhD, Gregory A Nuttall, MD, Joseph A Dearani, MD, Lisa M Schrader, MT, Darrell R Schroeder, MS, Mark H Ereth, MD, Francisco J Puga, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 127, Issue 6, Pages 1670-1677 (June 2004) DOI: 10.1016/j.jtcvs.2003.10.029

Figure 1 Plasma aprotinin concentrations determined for each patient at the following time intervals: (1) baseline (before aprotinin administration); (2) 5 minutes after aprotinin bolus; (3) 5 minutes after initiation of CPB; (4) 30 minutes during CPB; (5) 60 minutes during CPB; (6) discontinuation of aprotinin infusion; (7) 1 hour after aprotinin infusion was discontinued; and (8) 4 hours after permanent separation from CPB. Aprotinin was administered as a 25,000 KIU/kg bolus, 35,000 KIU/kg priming component, and 12,500 KIU · kg−1 · h−1 continuous infusion. One patient received full dose (280 mg bolus, 280 mg prime, and 70 mg/h continuous infusion), and 2 patients received half dose (140 mg bolus, 140 mg prime, and 35 mg/h continuous infusion). All of these patients weighed more than 40 kg. *Significant difference across weight groups (P < .05, 1-way analysis of variance). CPB, Cardiopulmonary bypass; KIU, kallikrein-inhibiting unit. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1670-1677DOI: (10.1016/j.jtcvs.2003.10.029)

Figure 2 Plasma aprotinin concentrations 5 minutes after the bolus of aprotinin according to weight. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1670-1677DOI: (10.1016/j.jtcvs.2003.10.029)

Figure 3 Plasma aprotinin concentrations 5 minutes after the initiation of CPB according to weight. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1670-1677DOI: (10.1016/j.jtcvs.2003.10.029)